New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma by Cong Luo, Xingxing Min, Danying Zhang

“…It involves recent immunotherapy advances, including monoclonal antibodies, tumor vaccines, immune cell therapies, checkpoint inhibitors, and oncolytic viruses, and discusses combining these with standard treatments.…”
Get full text

The mental health implication of mpox: Enhancing care with genetic insights by Ovinuchi Ejiohuo

“…Furthermore, genetic insights can inform the development of safer vaccines and early interventions, particularly for vulnerable populations. …”
Get full text

Technological Cooperation Networks at Bio-Manguinhos: the Role of Information and Communication Technologies by Lázaro Pereira de Oliveira, Claudio Pitassi, Antônio Augusto Gonçalves

“…This article identifies and discusses the contribution of information and communication technologies (ICTs) to the technological cooperation projects of Bio-Manguinhos, a pharmaceutical manufacturer that belongs to Osvaldo Cruz Foundation (FIOCRUZ), responsible for producing vaccines, reagents and biopharmaceuticals, with priority on meeting the needs of the Brazilian public health system. …”
Get full text

Structural Predestination of Individual Diversity in the Course and Severity of Infectious Diseases by Sergey N. Rumyantsev

Get full text

Streptococcal Infections of Fish by Roy Yanong, Ruth Francis-Floyd

“…Preventive measures emphasize maintaining optimal water quality, minimizing stress, and employing vaccines and immunostimulants. Additionally, the document addresses the zoonotic potential of Streptococcus iniae, highlighting the low risk to healthy individuals but cautioning immunocompromised persons. …”
Get full text

Streptococcal Infections of Fish by Roy Yanong, Ruth Francis-Floyd

“…Preventive measures emphasize maintaining optimal water quality, minimizing stress, and employing vaccines and immunostimulants. Additionally, the document addresses the zoonotic potential of Streptococcus iniae, highlighting the low risk to healthy individuals but cautioning immunocompromised persons. …”
Get full text

The Role of Pneumococcal Virulence Factors in Ocular Infectious Diseases by Angela H. Benton, Mary E. Marquart

“…Though two pneumococcal vaccines exist for the prevention of nonocular diseases, they do little to fully prevent ocular infections. …”
Get full text

Development of ¹¹¹In-Labeled Monoclonal Antibodies Targeting SFTSV Structural Proteins for Molecular Imaging of SFTS Infectious Diseases by SPECT by Takeshi Fuchigami, Mya Myat Ngwe Tun, Yusuke Tanahara, Kodai Nishi, Sakura Yoshida, Kazuma Ogawa, Morio Nakayama, Daisuke Hayasaka

“…No effective vaccines or treatments are currently available for severe fever with thrombocytopenia syndrome (SFTS), a fatal tick-borne infectious disease caused by the SFTS virus (SFTSV). …”
Get full text

Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective me... by Jo Southern, Adam Finn, Catherine Hyams, James Campling, Bradford D Gessner, Elizabeth Begier, Maria Garcia Gonzalez, Sharon Gray, Jennifer Oliver

“…This may have significant consequences for healthcare planning, including usage of current and future vaccinations against respiratory infection.…”
Get full text

Research Note: Establishment of vector system harboring duck RNA polymerase I promoter for avian influenza virus by Yunyueng Jang, Yoon-Gi Baek, Yu-Na Lee, Ra Mi Cha, Yun-Chan Choi, Min-Ji Park, Youn-Jeong Lee, Eun-Kyoung Lee

“…Reverse genetics (RG) systems are extensively utilized to investigate the characteristics of influenza viruses and develop vaccines, predominantly relying on human RNA polymerase I (pol I). …”
Get full text

Human adenovirus species B knob proteins as immunogens for inducing cross-neutralizing antibody responses by Zhenwei Liu, Yuting Xian, Jixian Lan, Zhichao Zhou, Xiao Li, Rong Zhou, Dehui Chen, Xingui Tian

“…Therefore, the development of multivalent vaccines against HAdV types 3, 7, 14, and 55 remains an important goal. …”
Get full text

A phase I, randomized, placebo‐controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults by Xiaomeng Mao, Xiaohan Hua, Chengyi Wu, Xiaoyun Ge, Jie Zhang, Xiaojie Wu, Robert J. Kubiak, Ulrika Wählby Hamrén, Tonya Villafana, Georgios Christou, Jannine Green, Therese Takas, Yuwen Jin

Get full text

PROSTATE CANCER AND HIS INFLUENCE ON REPRODUCTIVE HEALTH by Nataliya Medvedovska, Volodymyr Podolskyi, Mykola Kvach, Iryna Stovban

“…Among the main factors that may influence this are the low level of vaccination of male and female population of Ukraine from highly oncogenic strains of human papillomavirus, lack of motivation of the male population of Ukraine to a comprehensive screening of the prostate after 45 years and low awareness of the need for such screening, availability of three-component vaccines against human papillomavirus on the pharmaceutical market of Ukraine, while vaccination with seven-component vaccines against this virus is routine in the European Union. …”
Get full text

Evaluation of the impact of the state of emergency during the COVID-19 pandemic on childhood immunizations in Benguela Province, Angola by Tadatsugu Imamura, Keiji Mochida, Balogun Olukunmi, Lino Tchicondingosse, Pedro Sapalalo, Ketha Rubuz Francisco, Ai Aoki, Akira Ishiguro, Kenji Takehara

“…The most common reason for missing immunization was vaccine unavailability at health units (19.9%, 684/3,440). …”
Get full text

Human Leukocyte Antigen Diversity: A Southern African Perspective by Mqondisi Tshabalala, Juanita Mellet, Michael S. Pepper

“…This information will support disease association studies, provide guidance in vaccine design, and improve transplantation outcomes.…”
Get full text

The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text

The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text

STUDYING IMMUNOBIOLOGICAL CHARACTERISTICS OF FMDV TYPE O ISOLATES RECOVERED IN THE SOUTH KOREA by A. A. Funtikov, S. R. Kremenchugskaya, T. K. Mayorova, S. N. Fomina, D. A. Lozovoy, V. M. Zaharov

“…Special attention was given to determination of the inoculation dose for virus cultivation in PSGK-30 for the purpose of subsequent preparation of antigenic preparations and FMD vaccines. The results of strain studies served a basis for their depositing into the FGBI “ARRIAH” strain collection.…”
Get full text

The effectiveness of dexamethasone as a combination therapy for COVID-19 by Namazi Nader

“…Coronavirus disease 2019 (COVID-19) was reported as a global pandemic in March 2020 after invading many countries and leaving behind tens of thousands of infected patients in a brief time span. Approval of a few vaccines has been obtained and their efficacy of varying degrees established. …”
Get full text

A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population by Kai Chin Poh, Victoria Yu Jia Tay, Sarah Huixin Lin, Huei Leng Chee, Suhitharan Thangavelautham

“…There is intensive research targeted at better understanding of the virus pathogenicity, development of effective treatment strategies and vaccines against COVID-19. It is increasingly being recognised that the pathogenicity of COVID-19 extends beyond the respiratory system. …”
Get full text